Az idiopathiás gyulladásos myopathiák krónikus, szisztémás autoimmun betegségek, amelyek a végtagizmok szimmetrikus, progresszív gyengeségével járnak. A betegség kezelése nagy gyakorlatot igénylő, összetett feladat. A közleményben a szerzők áttekintik a jelenleg rendelkezésre álló kezelési lehetőségeket idiopathiás gyulladásos myopathiákban, majd részletesen foglalkozunk az intravénás immunglobulin alkalmazhatóságával a terápiarefrakter esetekben. A szerzők célja, hogy minél több irodalmi példával, nemzetközi tapasztalattal támasszák alá a módszer hatékonyságát, figyelve előnyeire és esetleges hátrányaira is. Orv. Hetil., 2013, 154, 723–728. | Idiopathic inflammatory myopathies are chronic, systemic autoimmune diseases, character...
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of myositis, characterised by ch...
The aim of this retrospective study is to evaluate the efficacy and safety of intravenous immune glo...
Management of patients with idiopathic inflammatory myopathies (IIMs) is challenging given the syste...
Az idiopathiás inflammatorikus myopathiák szisztémás, a proximalis végtagizmok progresszív, szimmetr...
Az idiopathiás inflammatoricus myopathiák szisztémás, a proximalis végtagizmok szimmetrikus gyengesé...
Background: despite the absence of specific guidelines, the treatment with intravenous immunoglobuli...
Background: despite the absence of specific guidelines, the treatment with intravenous immunoglobuli...
Idiopathic inflammatory myopathies are a group of rare, disorders with the primary features of muscl...
Idiopathic inflammatory myopathies, such as polymyositis and dermatomyositis, share common clinical ...
Objectives: We explored efficacy and safety of IVIg as first-line treatment in patients with an idio...
A prospective open label trial of add on therapy with intravenous immunoglobulin (IVIg) was carried ...
Az idiopathiás inflammatoricus myopathiák krónikus immunmediált gyulladások. Közös jellegzetességük ...
The treatment of the immune-mediated inflammatory myopathies remains largely empirical. Corticostero...
A prospective open label trial of add on therapy with intravenous immunoglobulin (IVIg) was carried ...
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of myositis, characterised by ch...
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of myositis, characterised by ch...
The aim of this retrospective study is to evaluate the efficacy and safety of intravenous immune glo...
Management of patients with idiopathic inflammatory myopathies (IIMs) is challenging given the syste...
Az idiopathiás inflammatorikus myopathiák szisztémás, a proximalis végtagizmok progresszív, szimmetr...
Az idiopathiás inflammatoricus myopathiák szisztémás, a proximalis végtagizmok szimmetrikus gyengesé...
Background: despite the absence of specific guidelines, the treatment with intravenous immunoglobuli...
Background: despite the absence of specific guidelines, the treatment with intravenous immunoglobuli...
Idiopathic inflammatory myopathies are a group of rare, disorders with the primary features of muscl...
Idiopathic inflammatory myopathies, such as polymyositis and dermatomyositis, share common clinical ...
Objectives: We explored efficacy and safety of IVIg as first-line treatment in patients with an idio...
A prospective open label trial of add on therapy with intravenous immunoglobulin (IVIg) was carried ...
Az idiopathiás inflammatoricus myopathiák krónikus immunmediált gyulladások. Közös jellegzetességük ...
The treatment of the immune-mediated inflammatory myopathies remains largely empirical. Corticostero...
A prospective open label trial of add on therapy with intravenous immunoglobulin (IVIg) was carried ...
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of myositis, characterised by ch...
Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of myositis, characterised by ch...
The aim of this retrospective study is to evaluate the efficacy and safety of intravenous immune glo...
Management of patients with idiopathic inflammatory myopathies (IIMs) is challenging given the syste...